Mizuho analysts raised its price target ahead of Cardinal Health's earnings. The stock is testing a buy point after topping another entry. The post IBD Stock Of The Day Tests New Buy Point As Indicators Suggest More Upside appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real